A carregar...

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease

Background and aims: To verify whether targeting defective mucosal T cell death underlies the sustained therapeutic benefit of infliximab in Crohn’s disease, we explored its in vivo proapoptotic effect after 10 weeks of treatment, and its in vitro killing activity on lamina propria T cells (LPT) and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Di Sabatino, A, Ciccocioppo, R, Cinque, B, Millimaggi, D, Morera, R, Ricevuti, L, Cifone, M G, Corazza, G R
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2004 by Gut 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773915/
https://ncbi.nlm.nih.gov/pubmed/14684579
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!